The Oh Happy Day Class - Digital Connections (OHDC-DC): A Pilot Study

Depression Clinical Trial

— OHDC-DC  

Official title:

The Oh Happy Day Class - Digital Connections (OHDC-DC): an Exploratory Pilot Study

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06206226
• Other study ID #: 2023-1437
• Secondary ID: A532007SMPH/FAMI
• Status: Not yet recruiting
• Phase: N/A
• Start date: May 2024
• Est. completion date: April 2025

Study information

• Verified date: April 2024
• Source: University of Wisconsin, Madison
• Contact: Mary Checovich
• Phone: 608-263-2653
• Email: mary.checovich[@]fammed.wisc.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this clinical trial is to see if a mobile phone app can deliver depression treatment to African Americans who are depressed. The main question it aims to answer is if this treatment is effective in reducing symptoms of depression. Participants will attend six 90-minute weekly classes via an app on their phone, and will be asked to complete surveys every week. Participants can expect to be in the study for four months.

Description:

The Oh Happy Day Class-Digital Connections (OHDC-DC) is designed for African American adults experiencing clinical depression (CD). OHDC originally comprised of 13 treatment modules focused on culturally relevant strategies to increase knowledge of depression and healthy coping behaviors aimed at reducing symptoms of clinical depression and improving health outcomes. The Oh Happy Day Class-Digital Connections (OHDC-DC) comprise of 5 core elements of the OHDC-DC: 1. 90-minute-weekly cognitive behavioral psycho-education classes over a 6-week period. 2. Six classes will be offered and facilitated online in the computerized OHDC-DC. 3. Participants will be encouraged to stay engaged between classes by digitally connecting on the app with the class content. On the app they will receive reminders and messages from staff and participants to stay digitally connected and engaged. 4. Embedded in the classes and content is psychoeducation with an emphasis on educating participants about depression, raising awareness of mental illness with the goal of normalizing it and reducing stigma, and increasing healthy coping behaviors, and. 5. The intervention will be delivered by a licensed mental health clinician.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 8
• Est. completion date: April 2025
• Est. primary completion date: April 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• African-American
• Age 18 and older
• Experiencing depression (as evidenced by a score of 5 or higher on the PHQ-9)
• Own a mobile phone

Exclusion Criteria:

• Individuals who are currently receiving psychotherapy
• Individuals who are presently experiencing suicidal ideation
• Individuals who started psychotropic medication less than three months prior to the start of the OHDC will be excluded from the study
• Participants scoring 25 or higher on the PHQ-9 will be screened out

Related Conditions & MeSH terms

• Depression
• Depressive Disorder
• Depressive Symptoms

Intervention

Behavioral:
• OHDC-DC
90-minute-weekly cognitive behavioral psycho-education classes using a mobile phone app over a 6-week period

Locations

Country	Name	City	State
United States	University of Wisconsin	Madison	Wisconsin

Sponsors (1)

Lead Sponsor	Collaborator
University of Wisconsin, Madison

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Personal Health Questionnaire Depression Scale score	Using the 8 item Personal Health Questionnaire Depression Scale (PHQ-8), participants will rate how much they have been bothered by symptoms on a scale of 0-3 with a possible range of 0 to 24. Higher scores indicate greater degree of depression.	Baseline to one month post-intervention (approximately 12 weeks)
Primary	Change in Generalized Anxiety Disorder 7-item (GAD-7) score	Using the GAD-7 score, participants will rate how much they have been bothered by symptoms on a scale of 0-3 with a possible range of 0 to 24. Higher scores indicate greater degree of anxiety.	Baseline to one month post-intervention (approximately 12 weeks)
Primary	Change in Quick Inventory of Depressive Symptomatology (QIDS)	Using the 16-item QIDS, participants will rate how much they have been bothered by symptoms on a scale of 0-3 with a possible range of 0 to 27. Higher scores indicate greater degree of depression.	Baseline to one month post-intervention (approximately 12 weeks)
Primary	Satisfaction with intervention	Participants will rate their satisfaction with the intervention by answering a 9-item questionnaire with a scale of 1-7 (1= none of the time, 7= all of the time). Higher scores indicate greater satisfaction with the intervention.	12 weeks